G-Protein inwardly rectifying potassium channels are involved in the hypotensive effect of I1-imidazoline receptor selective ligands
G-Protein inwardly rectifying potassium channels are involved in the hypotensive effect of I1-imidazoline receptor selective ligands
复制标题
G蛋白内向整流钾通道参与I1-咪唑啉受体选择性配体的降血压作用
DOI:
10.1097/hjh.0b013e3282f5ed44
复制
发表时间:
2008
影响因子:
4.9
通讯作者:
J. Feldman
中科院分区:
文献类型:
--
作者:
Guata Yoro Sy;D. Urošević;L. Fellmann;H. Greney;P. Bousquet;J. Feldman
Objective The present study examined the role of G-protein inwardly rectifying potassium (GIRK) channels in the depressor responses elicited by intracisternal injections of imidazoline-like drugs in anesthetized rabbits. Methods and results Intracisternal injections of the I1-imidazoline receptor (I1R) selective ligands LNP509 (30 μg/kg) and LNP640 (2 μg/kg) (subthreshold doses), and of the GIRK channel opener flupirtine (30 μg/kg) did not affect mean arterial blood pressure (MAP). LNP509 and LNP640, however, elicited substantial depressor responses in rabbits pretreated with flupirtine (−17 ± 2 and −18 ± 1 mmHg, respectively, P < 0.05). Injection of higher doses of LNP509 (200 μg/kg) or LNP640 (10 μg/kg) elicited substantial reductions in MAP (−45 ± 3 and −39 ± 2 mmHg, respectively, P < 0.05) in naive rabbits. The depressor responses elicited by the higher doses of LNP509 or LNP640 were markedly diminished by pretreatment with the GIRK channel blocker tertiapin-Q (10 μg/kg) (−23 ± 3 and −26 ± 2 mmHg, respectively, P < 0.05 compared with nonpretreated rabbits), whereas tertiapin-Q (10 μg/kg) did not affect MAP by itself. Maximal-specific binding (Bmax) of the I1R ligand [125I]LNP911 to PC12 cell membranes (296 ± 59 fmol/mg protein) was enhanced by flupirtine pretreatment whereas it was reduced by tertiapin-Q pretreatment (687 ± 122 and 68 ± 21 fmol/mg protein, respectively, P < 0.05 vs. control binding). Conclusion These findings demonstrate that the modulation of GIRK channels affects I1R's function and raise the possibility that GIRK channels, and I1Rs are parts of a single proteic complex.
DOI:
--
发表时间:
1996
期刊:
Molecular pharmacology.
影响因子:
--
作者:
Separovic,D;Kester,M;Ernsberger,P
通讯作者:
Ernsberger,P
DOI:
--
发表时间:
1984-07
期刊:
The Journal of pharmacology and experimental therapeutics
影响因子:
--
作者:
P. Bousquet;J. Feldman;J. Schwartz
通讯作者:
P. Bousquet;J. Feldman;J. Schwartz
DOI:
--
发表时间:
1996
期刊:
The Journal of pharmacology and experimental therapeutics.
影响因子:
--
作者:
Piletz,JE;Zhu,H;Chikkala,DN
通讯作者:
Chikkala,DN